ZA200507298B - Antibody against tumor specific antigen as target - Google Patents

Info

Publication number

ZA200507298B

ZA200507298B ZA200507298A ZA200507298A ZA200507298B ZA 200507298 B ZA200507298 B ZA 200507298B ZA 200507298 A ZA200507298 A ZA 200507298A ZA 200507298 A ZA200507298 A ZA 200507298A ZA 200507298 B ZA200507298 B ZA 200507298B

Authority

ZA

South Africa

Prior art keywords

antibody

sequence

cancer

cells

protein

Prior art date

2003-03-10

Links

• Espacenet
• Global Dossier
• Discuss

• 206010028980 Neoplasm Diseases 0.000 title claims abstract description 122
• 108091007433 antigens Proteins 0.000 title description 46
• 102000036639 antigens Human genes 0.000 title description 46
• 239000000427 antigen Substances 0.000 title description 45
• 238000000034 method Methods 0.000 claims abstract description 255
• 101000759879 Homo sapiens Tetraspanin-10 Proteins 0.000 claims abstract description 186
• 102000043528 human TSPAN10 Human genes 0.000 claims abstract description 143
• 201000011510 cancer Diseases 0.000 claims abstract description 104
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 29
• 230000001472 cytotoxic effect Effects 0.000 claims abstract description 23
• 238000011282 treatment Methods 0.000 claims abstract description 22
• 210000004027 cell Anatomy 0.000 claims description 318
• 108090000623 proteins and genes Proteins 0.000 claims description 150
• 102000004169 proteins and genes Human genes 0.000 claims description 93
• 239000000126 substance Substances 0.000 claims description 89
• 239000002773 nucleotide Substances 0.000 claims description 74
• 125000003729 nucleotide group Chemical group 0.000 claims description 74
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 55
• 241000282414 Homo sapiens Species 0.000 claims description 51
• 210000004408 hybridoma Anatomy 0.000 claims description 49
• 239000000523 sample Substances 0.000 claims description 47
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 42
• 108091033319 polynucleotide Proteins 0.000 claims description 42
• 102000040430 polynucleotide Human genes 0.000 claims description 42
• 239000002157 polynucleotide Substances 0.000 claims description 42
• 239000000203 mixture Substances 0.000 claims description 37
• 201000001441 melanoma Diseases 0.000 claims description 35
• 230000027455 binding Effects 0.000 claims description 28
• 238000012360 testing method Methods 0.000 claims description 25
• 108091034117 Oligonucleotide Proteins 0.000 claims description 23
• 239000003814 drug Substances 0.000 claims description 21
• 238000002965 ELISA Methods 0.000 claims description 20
• 238000001514 detection method Methods 0.000 claims description 20
• 230000000295 complement effect Effects 0.000 claims description 17
• 238000013519 translation Methods 0.000 claims description 17
• 230000036961 partial effect Effects 0.000 claims description 15
• 208000000453 Skin Neoplasms Diseases 0.000 claims description 14
• 201000000849 skin cancer Diseases 0.000 claims description 14
• 238000001262 western blot Methods 0.000 claims description 12
• 239000003446 ligand Substances 0.000 claims description 8
• 238000003757 reverse transcription PCR Methods 0.000 claims description 8
• 230000001419 dependent effect Effects 0.000 claims description 7
• 238000003556 assay Methods 0.000 claims description 6
• 230000006698 induction Effects 0.000 claims description 6
• 108020004635 Complementary DNA Proteins 0.000 claims description 5
• 230000004540 complement-dependent cytotoxicity Effects 0.000 claims description 5
• 108020004414 DNA Proteins 0.000 claims description 4
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 231100000023 Cell-mediated cytotoxicity Toxicity 0.000 claims description 3
• 206010057250 Cell-mediated cytotoxicity Diseases 0.000 claims description 3
• 230000005890 cell-mediated cytotoxicity Effects 0.000 claims description 3
• 238000000636 Northern blotting Methods 0.000 claims description 2
• 102000006382 Ribonucleases Human genes 0.000 claims description 2
• 108010083644 Ribonucleases Proteins 0.000 claims description 2
• 230000006907 apoptotic process Effects 0.000 claims description 2
• 238000012216 screening Methods 0.000 abstract description 14
• 150000001875 compounds Chemical class 0.000 abstract description 12
• 108700020796 Oncogene Proteins 0.000 abstract description 3
• 239000003550 marker Substances 0.000 abstract description 3
• 230000002265 prevention Effects 0.000 abstract 1
• 239000000243 solution Substances 0.000 description 96
• 235000018102 proteins Nutrition 0.000 description 79
• 239000002609 medium Substances 0.000 description 71
• 101710133601 Tetraspanin-10 Proteins 0.000 description 64
• 102100024990 Tetraspanin-10 Human genes 0.000 description 63
• 239000002299 complementary DNA Substances 0.000 description 54
• 102100024952 Protein CBFA2T1 Human genes 0.000 description 48
• 241000699666 Mus <mouse, genus> Species 0.000 description 43
• 239000013598 vector Substances 0.000 description 40
• 239000012528 membrane Substances 0.000 description 38
• 239000013615 primer Substances 0.000 description 38
• 238000006243 chemical reaction Methods 0.000 description 37
• 239000006228 supernatant Substances 0.000 description 36
• 241001465754 Metazoa Species 0.000 description 31
• 239000013612 plasmid Substances 0.000 description 31
• 229940024606 amino acid Drugs 0.000 description 30
• 235000001014 amino acid Nutrition 0.000 description 30
• 150000001413 amino acids Chemical class 0.000 description 30
• 238000002360 preparation method Methods 0.000 description 30
• 108020004999 messenger RNA Proteins 0.000 description 26
• 125000000539 amino acid group Chemical group 0.000 description 22
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 21
• 239000002502 liposome Substances 0.000 description 21
• 210000001519 tissue Anatomy 0.000 description 21
• 238000005119 centrifugation Methods 0.000 description 20
• 230000000694 effects Effects 0.000 description 20
• 206010035226 Plasma cell myeloma Diseases 0.000 description 19
• 239000003795 chemical substances by application Substances 0.000 description 19
• 239000013604 expression vector Substances 0.000 description 18
• 201000000050 myeloid neoplasm Diseases 0.000 description 18
• 239000012979 RPMI medium Substances 0.000 description 17
• 229910002091 carbon monoxide Inorganic materials 0.000 description 17
• 230000003053 immunization Effects 0.000 description 17
• 108090000765 processed proteins & peptides Proteins 0.000 description 17
• 241000588724 Escherichia coli Species 0.000 description 16
• 238000009396 hybridization Methods 0.000 description 16
• 239000002953 phosphate buffered saline Substances 0.000 description 16
• 238000010367 cloning Methods 0.000 description 15
• 239000007789 gas Substances 0.000 description 15
• 238000002649 immunization Methods 0.000 description 15
• 210000004989 spleen cell Anatomy 0.000 description 15
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
• 230000000692 anti-sense effect Effects 0.000 description 14
• 230000006870 function Effects 0.000 description 14
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 13
• 108091028043 Nucleic acid sequence Proteins 0.000 description 13
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
• 239000007853 buffer solution Substances 0.000 description 13
• 239000012634 fragment Substances 0.000 description 13
• 229920001184 polypeptide Polymers 0.000 description 13
• 102000004196 processed proteins & peptides Human genes 0.000 description 13
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 13
• -1 ultrafiltration Substances 0.000 description 13
• 238000005406 washing Methods 0.000 description 13
• 239000012980 RPMI-1640 medium Substances 0.000 description 12
• 239000007983 Tris buffer Substances 0.000 description 12
• 241000700605 Viruses Species 0.000 description 12
• 210000000628 antibody-producing cell Anatomy 0.000 description 12
• 230000007910 cell fusion Effects 0.000 description 12
• 239000007788 liquid Substances 0.000 description 12
• 210000003491 skin Anatomy 0.000 description 12
• 239000000758 substrate Substances 0.000 description 12
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 11
• 108060003951 Immunoglobulin Proteins 0.000 description 11
• 238000004113 cell culture Methods 0.000 description 11
• 102000018358 immunoglobulin Human genes 0.000 description 11
• 210000001165 lymph node Anatomy 0.000 description 11
• 239000008188 pellet Substances 0.000 description 11
• 108020004705 Codon Proteins 0.000 description 10
• 102000004190 Enzymes Human genes 0.000 description 10
• 108090000790 Enzymes Proteins 0.000 description 10
• 241000700159 Rattus Species 0.000 description 10
• 229960000723 ampicillin Drugs 0.000 description 10
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 10
• 125000004429 atom Chemical group 0.000 description 10
• 239000002585 base Substances 0.000 description 10
• 239000000872 buffer Substances 0.000 description 10
• 230000002401 inhibitory effect Effects 0.000 description 10
• 239000002244 precipitate Substances 0.000 description 10
• 239000000047 product Substances 0.000 description 10
• 230000008685 targeting Effects 0.000 description 10
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 10
• 238000012258 culturing Methods 0.000 description 9
• 229940079593 drug Drugs 0.000 description 9
• 239000012091 fetal bovine serum Substances 0.000 description 9
• 229920000136 polysorbate Polymers 0.000 description 9
• 238000000746 purification Methods 0.000 description 9
• 239000012679 serum free medium Substances 0.000 description 9
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
• 241000699670 Mus sp. Species 0.000 description 8
• 108091034057 RNA (poly(A)) Proteins 0.000 description 8
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
• 238000004458 analytical method Methods 0.000 description 8
• 230000030833 cell death Effects 0.000 description 8
• 239000006285 cell suspension Substances 0.000 description 8
• 239000003153 chemical reaction reagent Substances 0.000 description 8
• 238000004587 chromatography analysis Methods 0.000 description 8
• 239000012894 fetal calf serum Substances 0.000 description 8
• 238000000684 flow cytometry Methods 0.000 description 8
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 210000002752 melanocyte Anatomy 0.000 description 8
• 239000013642 negative control Substances 0.000 description 8
• 239000011780 sodium chloride Substances 0.000 description 8
• 235000002639 sodium chloride Nutrition 0.000 description 8
• 235000000346 sugar Nutrition 0.000 description 8
• 239000000725 suspension Substances 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
• 108091060211 Expressed sequence tag Proteins 0.000 description 7
• 108700026244 Open Reading Frames Proteins 0.000 description 7
• 229930006000 Sucrose Natural products 0.000 description 7
• 238000003453 ammonium sulfate precipitation method Methods 0.000 description 7
• 238000001246 colloidal dispersion Methods 0.000 description 7
• 239000003085 diluting agent Substances 0.000 description 7
• 238000002523 gelfiltration Methods 0.000 description 7
• 239000001963 growth medium Substances 0.000 description 7
• 230000000670 limiting effect Effects 0.000 description 7
• 238000000302 molecular modelling Methods 0.000 description 7
• 102000039446 nucleic acids Human genes 0.000 description 7
• 108020004707 nucleic acids Proteins 0.000 description 7
• 150000007523 nucleic acids Chemical class 0.000 description 7
• 239000000546 pharmaceutical excipient Substances 0.000 description 7
• 238000001890 transfection Methods 0.000 description 7
• 229920000936 Agarose Polymers 0.000 description 6
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
• 238000002835 absorbance Methods 0.000 description 6
• 230000004071 biological effect Effects 0.000 description 6
• 229920002678 cellulose Polymers 0.000 description 6
• 235000010980 cellulose Nutrition 0.000 description 6
• 239000007795 chemical reaction product Substances 0.000 description 6
• 230000002950 deficient Effects 0.000 description 6
• 238000005516 engineering process Methods 0.000 description 6
• 230000004927 fusion Effects 0.000 description 6
• 238000012637 gene transfection Methods 0.000 description 6
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 6
• 229930027917 kanamycin Natural products 0.000 description 6
• 229960000318 kanamycin Drugs 0.000 description 6
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 6
• 229930182823 kanamycin A Natural products 0.000 description 6
• 150000002632 lipids Chemical class 0.000 description 6
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 6
• 230000035755 proliferation Effects 0.000 description 6
• 210000002966 serum Anatomy 0.000 description 6
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
• 239000005720 sucrose Substances 0.000 description 6
• 229940124597 therapeutic agent Drugs 0.000 description 6
• 238000005199 ultracentrifugation Methods 0.000 description 6
• OOIBFPKQHULHSQ-UHFFFAOYSA-N (3-hydroxy-1-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC2(O)CC1(OC(=O)C(=C)C)C3 OOIBFPKQHULHSQ-UHFFFAOYSA-N 0.000 description 5
• NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 5
• 206010003445 Ascites Diseases 0.000 description 5
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 5
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 5
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
• 239000006142 Luria-Bertani Agar Substances 0.000 description 5
• 101710120037 Toxin CcdB Proteins 0.000 description 5
• 210000000683 abdominal cavity Anatomy 0.000 description 5
• 239000001569 carbon dioxide Substances 0.000 description 5
• 229910002092 carbon dioxide Inorganic materials 0.000 description 5
• 239000001913 cellulose Substances 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 5
• 238000012790 confirmation Methods 0.000 description 5
• 239000012228 culture supernatant Substances 0.000 description 5
• 238000000502 dialysis Methods 0.000 description 5
• 238000010790 dilution Methods 0.000 description 5
• 239000012895 dilution Substances 0.000 description 5
• 239000012636 effector Substances 0.000 description 5
• 230000001747 exhibiting effect Effects 0.000 description 5
• 239000007850 fluorescent dye Substances 0.000 description 5
• 108020001507 fusion proteins Proteins 0.000 description 5
• 102000037865 fusion proteins Human genes 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 238000000338 in vitro Methods 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 238000001638 lipofection Methods 0.000 description 5
• 238000005259 measurement Methods 0.000 description 5
• 229920001223 polyethylene glycol Polymers 0.000 description 5
• 239000011535 reaction buffer Substances 0.000 description 5
• 230000002829 reductive effect Effects 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 241001430294 unidentified retrovirus Species 0.000 description 5
• WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• 244000063299 Bacillus subtilis Species 0.000 description 4
• 235000014469 Bacillus subtilis Nutrition 0.000 description 4
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• VYZAMTAEIAYCRO-BJUDXGSMSA-N Chromium-51 Chemical compound [51Cr] VYZAMTAEIAYCRO-BJUDXGSMSA-N 0.000 description 4
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
• 238000011238 DNA vaccination Methods 0.000 description 4
• 241000702421 Dependoparvovirus Species 0.000 description 4
• 102100034343 Integrase Human genes 0.000 description 4
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 4
• 239000002202 Polyethylene glycol Substances 0.000 description 4
• 238000002123 RNA extraction Methods 0.000 description 4
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
• 241000700618 Vaccinia virus Species 0.000 description 4
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
• WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 239000000074 antisense oligonucleotide Substances 0.000 description 4
• 238000012230 antisense oligonucleotides Methods 0.000 description 4
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
• 239000012148 binding buffer Substances 0.000 description 4
• 229960002685 biotin Drugs 0.000 description 4
• 235000020958 biotin Nutrition 0.000 description 4
• 239000011616 biotin Substances 0.000 description 4
• 239000012888 bovine serum Substances 0.000 description 4
• 210000000170 cell membrane Anatomy 0.000 description 4
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
• 238000003113 dilution method Methods 0.000 description 4
• 201000010099 disease Diseases 0.000 description 4
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
• 238000001962 electrophoresis Methods 0.000 description 4
• 239000012149 elution buffer Substances 0.000 description 4
• 239000003995 emulsifying agent Substances 0.000 description 4
• 239000013613 expression plasmid Substances 0.000 description 4
• 239000000796 flavoring agent Substances 0.000 description 4
• 239000012530 fluid Substances 0.000 description 4
• 238000001415 gene therapy Methods 0.000 description 4
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
• 230000002163 immunogen Effects 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 210000003205 muscle Anatomy 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 229920003023 plastic Polymers 0.000 description 4
• 239000004033 plastic Substances 0.000 description 4
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
• 238000003752 polymerase chain reaction Methods 0.000 description 4
• 239000013641 positive control Substances 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 238000010187 selection method Methods 0.000 description 4
• 229940083575 sodium dodecyl sulfate Drugs 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 239000000600 sorbitol Substances 0.000 description 4
• 210000000952 spleen Anatomy 0.000 description 4
• 238000007447 staining method Methods 0.000 description 4
• 238000002560 therapeutic procedure Methods 0.000 description 4
• 229940104230 thymidine Drugs 0.000 description 4
• 238000002054 transplantation Methods 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
• XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• 101100028791 Caenorhabditis elegans pbs-5 gene Proteins 0.000 description 3
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 239000004375 Dextrin Substances 0.000 description 3
• 229920001353 Dextrin Polymers 0.000 description 3
• 108010067770 Endopeptidase K Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 239000007995 HEPES buffer Substances 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 229930195725 Mannitol Natural products 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 229920000881 Modified starch Polymers 0.000 description 3
• 239000000020 Nitrocellulose Substances 0.000 description 3
• 239000004677 Nylon Substances 0.000 description 3
• 229920001213 Polysorbate 20 Polymers 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
• 108010090804 Streptavidin Proteins 0.000 description 3
• 239000007984 Tris EDTA buffer Substances 0.000 description 3
• 108700005077 Viral Genes Proteins 0.000 description 3
• 230000002378 acidificating effect Effects 0.000 description 3
• 238000001042 affinity chromatography Methods 0.000 description 3
• 229960003896 aminopterin Drugs 0.000 description 3
• 239000012752 auxiliary agent Substances 0.000 description 3
• 229960000686 benzalkonium chloride Drugs 0.000 description 3
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 3
• 230000036952 cancer formation Effects 0.000 description 3
• 125000004432 carbon atom Chemical group C* 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• 235000019425 dextrin Nutrition 0.000 description 3
• 239000012470 diluted sample Substances 0.000 description 3
• 238000009510 drug design Methods 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 235000019634 flavors Nutrition 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 229960002989 glutamic acid Drugs 0.000 description 3
• 210000005260 human cell Anatomy 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000003100 immobilizing effect Effects 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 238000005342 ion exchange Methods 0.000 description 3
• 238000004255 ion exchange chromatography Methods 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 239000000594 mannitol Substances 0.000 description 3
• 235000010355 mannitol Nutrition 0.000 description 3
• 238000000691 measurement method Methods 0.000 description 3
• 238000002493 microarray Methods 0.000 description 3
• 238000002156 mixing Methods 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 235000019426 modified starch Nutrition 0.000 description 3
• 230000003472 neutralizing effect Effects 0.000 description 3
• 229920001220 nitrocellulos Polymers 0.000 description 3
• 229920001778 nylon Polymers 0.000 description 3
• 150000003904 phospholipids Chemical class 0.000 description 3
• 229920002401 polyacrylamide Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
• XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 3
• 238000012163 sequencing technique Methods 0.000 description 3
• 210000004927 skin cell Anatomy 0.000 description 3
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
• 239000012064 sodium phosphate buffer Substances 0.000 description 3
• 210000001541 thymus gland Anatomy 0.000 description 3
• 230000005030 transcription termination Effects 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 210000004881 tumor cell Anatomy 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• 238000002424 x-ray crystallography Methods 0.000 description 3
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
• IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 2
• HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
• LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 2
• 229960005508 8-azaguanine Drugs 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• 238000011725 BALB/c mouse Methods 0.000 description 2
• 229920001342 Bakelite® Polymers 0.000 description 2
• VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
• 241000283707 Capra Species 0.000 description 2
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
• 102000012410 DNA Ligases Human genes 0.000 description 2
• 108010061982 DNA Ligases Proteins 0.000 description 2
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 241000991587 Enterovirus C Species 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 229930186217 Glycolipid Natural products 0.000 description 2
• ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• 239000000232 Lipid Bilayer Substances 0.000 description 2
• 239000012097 Lipofectamine 2000 Substances 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• XEQLGWAGMYUVTR-UHFFFAOYSA-N O=C1NC=NC2=C1NC=N2.C1=CN=C2C(=O)NC(NN)=NC2=N1 Chemical compound O=C1NC=NC2=C1NC=N2.C1=CN=C2C(=O)NC(NN)=NC2=N1 XEQLGWAGMYUVTR-UHFFFAOYSA-N 0.000 description 2
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
• 102000004316 Oxidoreductases Human genes 0.000 description 2
• 108090000854 Oxidoreductases Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 102000003992 Peroxidases Human genes 0.000 description 2
• 241000276498 Pollachius virens Species 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
• 101710183280 Topoisomerase Proteins 0.000 description 2
• 239000013504 Triton X-100 Substances 0.000 description 2
• 229920004890 Triton X-100 Polymers 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 239000001361 adipic acid Substances 0.000 description 2
• 235000011037 adipic acid Nutrition 0.000 description 2
• 210000001789 adipocyte Anatomy 0.000 description 2
• 238000005377 adsorption chromatography Methods 0.000 description 2
• 238000000137 annealing Methods 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 238000013459 approach Methods 0.000 description 2
• 238000003491 array Methods 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 235000013539 calcium stearate Nutrition 0.000 description 2
• 239000008116 calcium stearate Substances 0.000 description 2
• OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
• 230000005907 cancer growth Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 229940107161 cholesterol Drugs 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 208000030381 cutaneous melanoma Diseases 0.000 description 2
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 230000008021 deposition Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 2
• 241001493065 dsRNA viruses Species 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 235000019441 ethanol Nutrition 0.000 description 2
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
• 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
• 230000005284 excitation Effects 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000000706 filtrate Substances 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 235000004554 glutamine Nutrition 0.000 description 2
• 235000011187 glycerol Nutrition 0.000 description 2
• 229960002449 glycine Drugs 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 210000003917 human chromosome Anatomy 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
• 230000001965 increasing effect Effects 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 238000007798 limiting dilution analysis Methods 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 210000005229 liver cell Anatomy 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
• 229960002216 methylparaben Drugs 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• 238000000520 microinjection Methods 0.000 description 2
• 239000007758 minimum essential medium Substances 0.000 description 2
• 239000002808 molecular sieve Substances 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 238000006386 neutralization reaction Methods 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 108040007629 peroxidase activity proteins Proteins 0.000 description 2
• 235000021317 phosphate Nutrition 0.000 description 2
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
• 239000013600 plasmid vector Substances 0.000 description 2
• 229910052697 platinum Inorganic materials 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 229920006316 polyvinylpyrrolidine Polymers 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 230000001376 precipitating effect Effects 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 239000012723 sample buffer Substances 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 238000000926 separation method Methods 0.000 description 2
• 150000004760 silicates Chemical class 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 239000002002 slurry Substances 0.000 description 2
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
• 235000017557 sodium bicarbonate Nutrition 0.000 description 2
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• 229910052938 sodium sulfate Inorganic materials 0.000 description 2
• 235000011152 sodium sulphate Nutrition 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 235000010199 sorbic acid Nutrition 0.000 description 2
• 239000004334 sorbic acid Substances 0.000 description 2
• 229940075582 sorbic acid Drugs 0.000 description 2
• 238000001179 sorption measurement Methods 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
• 239000013589 supplement Substances 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
• 229940033663 thimerosal Drugs 0.000 description 2
• 239000012096 transfection reagent Substances 0.000 description 2
• 230000009261 transgenic effect Effects 0.000 description 2
• 230000001052 transient effect Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 238000010396 two-hybrid screening Methods 0.000 description 2
• 238000000108 ultra-filtration Methods 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 108700026220 vif Genes Proteins 0.000 description 2
• JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
• BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
• XSYUPRQVAHJETO-WPMUBMLPSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-(1h-imidaz Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 XSYUPRQVAHJETO-WPMUBMLPSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
• NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
• TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
• UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
• KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
• 239000005995 Aluminium silicate Substances 0.000 description 1
• 239000004382 Amylase Substances 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 206010055113 Breast cancer metastatic Diseases 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 241000725101 Clea Species 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 235000005956 Cosmos caudatus Nutrition 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 229920002785 Croscarmellose sodium Polymers 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• 229920002271 DEAE-Sepharose Polymers 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 230000007018 DNA scission Effects 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 229910052693 Europium Inorganic materials 0.000 description 1
• 238000002377 Fourier profilometry Methods 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102000005720 Glutathione transferase Human genes 0.000 description 1
• 108010070675 Glutathione transferase Proteins 0.000 description 1
• JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
• ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 101000935587 Homo sapiens Flavin reductase (NADPH) Proteins 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 1
• LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• 102220470475 L-seryl-tRNA(Sec) kinase_C57L_mutation Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 238000003231 Lowry assay Methods 0.000 description 1
• 238000009013 Lowry's assay Methods 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 239000004368 Modified starch Substances 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
• 101150046281 NIP4-1 gene Proteins 0.000 description 1
• 238000005481 NMR spectroscopy Methods 0.000 description 1
• 229920002274 Nalgene Polymers 0.000 description 1
• 241001045988 Neogene Species 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 239000012124 Opti-MEM Substances 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108010067902 Peptide Library Proteins 0.000 description 1
• 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
• 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 239000004743 Polypropylene Substances 0.000 description 1
• 229920001214 Polysorbate 60 Polymers 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 108700020978 Proto-Oncogene Proteins 0.000 description 1
• 102000052575 Proto-Oncogene Human genes 0.000 description 1
• 239000004373 Pullulan Substances 0.000 description 1
• 229920001218 Pullulan Polymers 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 101710141795 Ribonuclease inhibitor Proteins 0.000 description 1
• 229940122208 Ribonuclease inhibitor Drugs 0.000 description 1
• 102100037968 Ribonuclease inhibitor Human genes 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241000801924 Sena Species 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
• 239000004163 Spermaceti wax Substances 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• 101150056072 TUFB gene Proteins 0.000 description 1
• 241001365914 Taira Species 0.000 description 1
• 108010006785 Taq Polymerase Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 238000002441 X-ray diffraction Methods 0.000 description 1
• ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 239000008351 acetate buffer Substances 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 210000000577 adipose tissue Anatomy 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 238000001261 affinity purification Methods 0.000 description 1
• 229940116024 aftera Drugs 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 238000000246 agarose gel electrophoresis Methods 0.000 description 1
• 230000004520 agglutination Effects 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 238000013019 agitation Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 150000005215 alkyl ethers Chemical class 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
• 235000012211 aluminium silicate Nutrition 0.000 description 1
• 229910000323 aluminium silicate Inorganic materials 0.000 description 1
• WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 230000003698 anagen phase Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 239000003945 anionic surfactant Substances 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 229940124411 anti-hiv antiviral agent Drugs 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 238000011091 antibody purification Methods 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 239000012062 aqueous buffer Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 235000009697 arginine Nutrition 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 239000000823 artificial membrane Substances 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• 229940050390 benzoate Drugs 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
• WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• 229960001948 caffeine Drugs 0.000 description 1
• VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 235000012215 calcium aluminium silicate Nutrition 0.000 description 1
• 229910000019 calcium carbonate Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
• 239000000378 calcium silicate Substances 0.000 description 1
• 229910052918 calcium silicate Inorganic materials 0.000 description 1
• OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
• 239000012830 cancer therapeutic Substances 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 229940105329 carboxymethylcellulose Drugs 0.000 description 1
• 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
• 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 239000003093 cationic surfactant Substances 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 229930183167 cerebroside Natural products 0.000 description 1
• RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
• JFRSSYYNWAGMIW-UHFFFAOYSA-M cesium;guanidine;thiocyanic acid;chloride Chemical compound [Cl-].[Cs+].SC#N.NC(N)=N JFRSSYYNWAGMIW-UHFFFAOYSA-M 0.000 description 1
• 239000002738 chelating agent Substances 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 229960003260 chlorhexidine Drugs 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 210000003161 choroid Anatomy 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 230000005757 colony formation Effects 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 230000030944 contact inhibition Effects 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 239000013601 cosmid vector Substances 0.000 description 1
• 229930003836 cresol Natural products 0.000 description 1
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 229940071120 dehydroacetate Drugs 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• JIONSDIFUGDYLD-UHFFFAOYSA-N diaminomethylideneazanium;phenol;thiocyanate Chemical compound [S-]C#N.NC([NH3+])=N.OC1=CC=CC=C1 JIONSDIFUGDYLD-UHFFFAOYSA-N 0.000 description 1
• 235000019700 dicalcium phosphate Nutrition 0.000 description 1
• 239000005546 dideoxynucleotide Substances 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 238000002050 diffraction method Methods 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 150000002016 disaccharides Chemical class 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 210000003754 fetus Anatomy 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 229960001269 glycine hydrochloride Drugs 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 229960004198 guanidine Drugs 0.000 description 1
• 229960000789 guanidine hydrochloride Drugs 0.000 description 1
• TZZZDHRJSLJNBU-UHFFFAOYSA-N guanidine;thiocyanic acid;hydrochloride Chemical compound Cl.SC#N.NC(N)=N.NC(N)=N TZZZDHRJSLJNBU-UHFFFAOYSA-N 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 238000000703 high-speed centrifugation Methods 0.000 description 1
• 235000014304 histidine Nutrition 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229960002163 hydrogen peroxide Drugs 0.000 description 1
• 229920001477 hydrophilic polymer Polymers 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 229940027941 immunoglobulin g Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000008011 inorganic excipient Substances 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 239000007928 intraperitoneal injection Substances 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 210000002429 large intestine Anatomy 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 210000000088 lip Anatomy 0.000 description 1
• 125000003473 lipid group Chemical group 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 239000012263 liquid product Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 235000018977 lysine Nutrition 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
• 239000000347 magnesium hydroxide Substances 0.000 description 1
• 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
• 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
• 230000007257 malfunction Effects 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 229940034008 mannitol / sorbitol Drugs 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910000000 metal hydroxide Inorganic materials 0.000 description 1
• 150000004692 metal hydroxides Chemical class 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 210000000479 mitotic spindle apparatus Anatomy 0.000 description 1
• ODLHGICHYURWBS-FOSILIAISA-N molport-023-220-444 Chemical compound CC(O)COC[C@@H]([C@@H]([C@H]([C@@H]1O)O)O[C@@H]2O[C@H]([C@H](O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3O[C@@H](COCC(C)O)[C@@H]([C@H]([C@@H]3O)O)O3)[C@@H](O)[C@@H]2O)COCC(O)C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3O[C@H]1COCC(C)O ODLHGICHYURWBS-FOSILIAISA-N 0.000 description 1
• 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
• 150000002772 monosaccharides Chemical class 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 239000002088 nanocapsule Substances 0.000 description 1
• 210000001989 nasopharynx Anatomy 0.000 description 1
• 101150091879 neo gene Proteins 0.000 description 1
• 238000007857 nested PCR Methods 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 239000002736 nonionic surfactant Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 230000037311 normal skin Effects 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000008012 organic excipient Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 206010033675 panniculitis Diseases 0.000 description 1
• 230000005298 paramagnetic effect Effects 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000036285 pathological change Effects 0.000 description 1
• 231100000915 pathological change Toxicity 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 210000003899 penis Anatomy 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 210000003800 pharynx Anatomy 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 150000002989 phenols Chemical class 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• 229940067107 phenylethyl alcohol Drugs 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 125000001095 phosphatidyl group Chemical group 0.000 description 1
• 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
• 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
• 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229940068968 polysorbate 80 Drugs 0.000 description 1
• 229940068965 polysorbates Drugs 0.000 description 1
• GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 229960003415 propylparaben Drugs 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 210000004777 protein coat Anatomy 0.000 description 1
• 238000000164 protein isolation Methods 0.000 description 1
• 230000006920 protein precipitation Effects 0.000 description 1
• 235000019423 pullulan Nutrition 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 239000003161 ribonuclease inhibitor Substances 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 229940102127 rubidium chloride Drugs 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000005204 segregation Methods 0.000 description 1
• RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
• 235000012239 silicon dioxide Nutrition 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 201000003708 skin melanoma Diseases 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
• 239000004299 sodium benzoate Substances 0.000 description 1
• 235000010234 sodium benzoate Nutrition 0.000 description 1
• PXLIDIMHPNPGMH-UHFFFAOYSA-N sodium chromate Chemical compound [Na+].[Na+].[O-][Cr]([O-])(=O)=O PXLIDIMHPNPGMH-UHFFFAOYSA-N 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
• 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 235000019385 spermaceti wax Nutrition 0.000 description 1
• 150000003408 sphingolipids Chemical class 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 229910001220 stainless steel Inorganic materials 0.000 description 1
• 239000010935 stainless steel Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 210000004304 subcutaneous tissue Anatomy 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 238000011410 subtraction method Methods 0.000 description 1
• 150000005846 sugar alcohols Chemical class 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 238000010998 test method Methods 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 210000002105 tongue Anatomy 0.000 description 1
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 101150099542 tuf gene Proteins 0.000 description 1
• 101150071165 tuf1 gene Proteins 0.000 description 1
• 101150010742 tuf2 gene Proteins 0.000 description 1
• 229910021642 ultra pure water Inorganic materials 0.000 description 1
• 239000012498 ultrapure water Substances 0.000 description 1
• 239000002691 unilamellar liposome Substances 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 210000004291 uterus Anatomy 0.000 description 1
• 210000003462 vein Anatomy 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1